Search Results - "Gill, Jonathan Benjamin"

A phase 1 dose escalation trial of ex-vivo expanded allogeneic cord blood–derived natural killer cell immunotherapy for pediatric solid tumor malignancies by Khazal, Sajad, Gill, Jonathan Benjamin, Foglesong, Jessica, Yedururi, Sireesha, Morani, Ajaykumar, Sui, Dawen, Bassett, Roland L., Gettys, Suzanne, Tewari, Priti, Mahadeo, Kris, Gorlick, Richard Greg, Shpall, Elizabeth J., Rezvani, Katy, Daw, Najat C.

“…2546 Background: Despite aggressive multimodality therapy, survival outcomes of most patients with recurrent/refractory solid tumors remain dismal. Preclinical…”
Get full text

Abstract 3110: ICAM-1(CD54) mediated bi-lineage differentiation in osteosarcoma by Kannan, Sankaranarayanan, Zhang, Yidan, Wang, Yifei, Jusu, Sylvester, Zhang, Zhongting, Wendong, Zhang, Xu, Zhaohui, Roth, Michaeal, Benjamin, Gill Jonathan, Gorlick, Richard

“…Introduction: Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. The cell of origin in OS is still not known, however, OS…”
Get full text

Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma (ARMS) patients on front-line therapies: An MD Anderson Cancer Center (MDACC) case series by Nakazawa, Michael, Livingston, J Andrew Andrew, Bishop, Andrew Justin, Zarzour, Maria Alejandra, Somaiah, Neeta, Ratan, Ravin, Gill, Jonathan Benjamin, Urquiola, Elizabeth, Posey, Kristi, Guadagnolo, Beverly Ashleigh, Gorlick, Richard Greg, Benjamin, Robert S., Patel, Shreyaskumar, Conley, Anthony Paul

“…e23548 Background: Rhabdomyosarcomas are the most common soft tissue sarcoma in children, and the prognosis of pediatric ARMS has improved with the use of…”
Get full text

Abstract 82: Transforming of human osteoblasts with the combination of hTERT (T), SV40Tag (S) and c-Myc: Changes in phenotype and tumorigenesis capability by Zhang, Zhongting, Wang, Yifei, Zhang, Wendong, Roth, Michael, Gill, Jonathan Benjamin, Xu, Zhaohui, Tian, Xiangjun, Wang, Jing, Gorlick, Richard

“…The etiology of osteosarcoma (OS), the most common primary malignant bone cancer in pediatric patients, still remains unknown. It is not clear where tat which…”
Get full text

Frequency and spectrum of clinically significant molecular alterations detected by tumor gene panel testing for pediatric cancer patients in the Texas KidsCanSeq study by Lin, Frank Y., Reuther, Jacquelyn, Potter, Samara L, Mangum, Ross, Mohila, Carrie A, Hicks, John, Muzny, Donna M., Bernini, Juan Carlos, Gill, Jonathan Benjamin, Griffin, Timothy Cameron, Tomlinson, Gail Elizabeth, Vallance, Kelly L., Foster, Jennifer, Allen, Carl E., Chintagumpala, Murali M., López-Terrada, Dolores H., Fisher, Kevin, Roy, Angshumoy, Plon, Sharon E., Parsons, Donald Williams

“…10018 Background: Tumor sequencing has the potential to inform diagnosis, prognosis, and treatment of childhood cancer patients. Prospective data are needed to…”
Get full text

Off label targeted therapy use in adolescents and young adults with sarcoma by Kopp, Lisa M., Saboda, Kathylynn, Setty, Bhuvana, Wedekind, Mary Frances, Weiser, Daniel, Schwartz, Leya, Isakoff, Michael, Harrison, Douglas James, Gill, Jonathan Benjamin, Hingorani, Pooja

“…Abstract only e21504 Background: Outcomes for patients with metastatic or recurrent sarcomas remains dismal with < 20% overall survival. Due to the rarity of…”
Get full text

Evaluation of the TPO-receptor agonist Eltrombopag in the Pediatric Preclinical Testing Consortium osteosarcoma in vivo models by Roth, Michael, Nevil, Grace, Gill, Jonathan Benjamin, Zhang, Wendong, Teicher, Beverly A., Erickson, Stephen W, Gatto, Gregory, Smith, Malcolm A., Kolb, E. Anders, Gorlick, Richard Greg

“…Abstract only e22502 Background: Eltrombopag (EP) is a small molecule, thrombopoietin receptor (TPO-R) agonist indicated for the treatment of patients with…”
Get full text

A phase I trial of aerosol gemcitabine for the treatment of patients with solid tumors and lung metastases by Gordon, Nancy Beatriz, Kleinerman, Eugenie, Sheshadri, Ajay, Blanco, David, Yedururi, Sireesha, Morani, Ajaykumar, Gill, Jonathan Benjamin, Harrison, Douglas James, Herzog, Cynthia E., Livingston, J Andrew, Benjamin, Robert S., Gorlick, Richard Greg, Mireles, Maria E, Kawedia, Jitesh D, Daw, Najat C.

“…Abstract only TPS3645 Background: Pre-clinical studies of aerosol gemcitabine (GCB) in mice and dogs with osteosarcoma (OS) lung metastases demonstrated…”
Get full text

Cell-surface vimentin positive circulating tumor cells as a diagnostic and prognostic indicator in pediatric sarcoma patients by Dao, Long, Ragoonanan, Dristhi, Foglesong, Jessica, Batth, Izhar Singh, Zaky, Wafik Tharwat, Gill, Jonathan Benjamin, Liu, Diane D., Albert, Aisha, Gordon, Nancy Beatriz, Huh, Winston W., Harrison, Douglas James, Herzog, Cynthia E., Kleinerman, Eugenie, Gorlick, Richard Greg, Daw, Najat C., Li, Shulin

“…Abstract only e15022 Background: Despite advances in care, the 5 year overall survival for patients with relapsed and or metastatic sarcoma remains as low as <…”
Get full text

Evaluation of the multi-kinase inhibitor regorafenib in the Pediatric Preclinical Testing Consortium osteosarcoma, rhabdomyosarcoma, and Ewing sarcoma in vivo models by Harrison, Douglas James, Gill, Jonathan Benjamin, Roth, Michael, Zhang, Wendong, Teicher, Beverly, Erickson, Stephen W, Gatto, Gregory, Kurmasheva, Raushan, Houghton, Peter, Smith, Malcolm A., Kolb, E. Anders, Gorlick, Richard Greg

“…Abstract only 10038 Background: Regorafenib is a multi-kinase inhibitor, developed by adding a fluorine atom to the phenyl ring of sorafenib. Regorafenib…”
Get full text

Pediatric oncology provider views on biopsying solid tumors in children with relapsed or refractory disease for the purpose of genomic profiling by Cohen, Barrie, Roth, Michael, Marron, Jonathan Michael, Gray, Stacy W., Geller, David, Hoang, Bang H, Gorlick, Richard Greg, Janeway, Katherine A., Gill, Jonathan Benjamin

“…Abstract only…”
Get full text

A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, doxorubicin, and PEG-asparaginase (VPLD) by Barredo, Julio C., Goldberg, John M., Hale, Gregory, Gill, Jonathan Benjamin, Setty, Bhuvana, Smith, Tiffany, Lee, Jae K, Reed, Damon R.

“…Abstract only…”
Get full text

A bi-shRNA furin and GMCSF engineered autologous tumor cell immunotherapy vs. gemcitabine + docetaxel for Ewing sarcoma and with cryoablation in Ewing family tumors by Anderson, Peter Meade, Ghisoli, Maurizio, Barve, Minal A., Gill, Jonathan Benjamin, Wexler, Leonard H., DeAngulo, Guillermo, Neville, Kathleen, Manning, Luisa, Wallraven, Gladice, Senzer, Neil N., Birkhofer, Martin, Nemunaitis, John J.

“…Abstract only TPS11079 Background: Vigil, an immuno-stimulatory autologous cellular therapy, uses patient tumor cells transfected with a plasmid encoding genes…”
Get full text